Drugs of Abuse Testing: Technologies and Global Markets
Report Scope:
The current report offers a detailed picture of the drug abuse testing market.
This report highlights the current and future market potential for drug abuse testing and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities, and trends in the market. The report also covers market projections through 2027 and key market players.
This report discusses drug abuse testing and its various resources. It covers the overall drug abuse testing market, including drug testing products. The report further analyzes the market based on products, covering analyzers, consumables, laboratory services, and point-of-care devices. In addition, the report also analyzes various sample types in drug abuse testing that include blood, hair, sweat, oral, urine, and others. Furthermore, a complete regional analysis of the market is also presented in the report.
Based on geography, the market has been segmented into North America, Europe, Asia-Pacific, and the Rest of the World (which includes Latin America, the Middle East and Africa). Detailed analyses of major countries (the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China, and India) are covered in regional segments. For market estimates, data has been provided for 2021 as the base year, with forecasts for 2022 through 2027. Estimated values are based on revenue generated by drug abuse testing companies as total revenues. Projected and forecasted revenue values are in constant U.S. dollars that have not been adjusted for inflation.
Report Includes:
23 data tables and 42 additional tables
A comprehensive overview and an up-to-date analysis of the global markets for drugs of abuse (DOA) testing
Analyses of the global market trends, with historic market revenue (sales figures) for 2021, estimates for 2022, forecasts for 2023, and projections of compound annual growth rates (CAGRs) through 2027
Highlights of the upcoming market potential for DOA testing industry along with a detailed analysis of the competitive environment, industry trends, opportunities and penetration of emerging technologies within the marketplace
Estimation of the actual market size and revenue forecast for the global drug abuse testing market in USD million values, and its corresponding market share analysis based on the product, sample type, drug type, testing type, end user, and region
Technology assessment of the current and possible future legislation affecting the market in the U.S. and other emerging economies, and their influence in the market developments
Statistical information covering drug abuse along with its trends as well as drug classes across the key geographic regions
A comparative study and Porter’s Five Forces analysis considering both the micro and macro environmental factors prevailing in the market for drugs of abuse testing
Review of the key patent grants and patent applications on drug abuse testing technologies
Identification of the major stakeholders and analysis of the company competitive landscape based on their recent market developments, financial performance, and segmental revenues
Descriptive company profiles of the leading global players, including Abbott Laboratories, Beckmann Coulter (Danaher Corp.), Roche Diagnostics, Quest Diagnostics Inc., LifeSign and Thermo Fisher Scientific Inc.
Companies Mentioned
ABBOTT DIAGNOSTICS
ACON LABORATORIES INC.
AGILENT TECHNOLOGIES, INC.
ALFA SCIENTIFIC DESIGNS, INC.
AMERICAN BIO MEDICA
BIO-RAD LABORATORIES, INC.
CONFIRM BIOSCIENCES
DANAHER CORP.
F. HOFFMANN-LA ROCHE LTD.
Identa Corp.
LIFESIGN LLC
MAVAND SOLUTIONS
MEDTOX DIAGNOSTICS
MOSSMAN ASSOCIATES
MP BIOMEDICALS
NANO-DITECH CORP.
One Step Detect Associates
ORASURE
ORTHO-CLINICAL DIAGNOSTICS
PRECHEK BIO
PRINCETON BIOMEDITECH
PSYCHEMEDICS
QUEST DIAGNOSTICS INC.
RANDOX LABORATORIES LTD.
REDWOOD TOXICOLOGY LABORATORY, INC.
SHIMADZU CORP.
SIEMENS HEALTHINEERS
THERMO FISHER SCIENTIFIC, INC.
UCP BIOSCIENCES"
- Chapter 1 Introduction
- 1.1 Study Goals and Objectives
- 1.2 Reasons for Doing This Study
- 1.3 What's New in this Update?
- 1.4 Scope of Report
- 1.5 Information Sources
- 1.6 Methodology
- 1.7 Geographic Breakdown
- 1.8 Analyst's Credentials
- 1.9 BCC Custom Research
- 1.10 Related BCC Research Reports
- Chapter 2 Summary and Highlights
- Chapter 3 Market and Technology Background
- 3.1 Overview
- 3.2 Testing Technologies
- 3.2.1 Urine Testing
- 3.2.2 Other Testing
- 3.3 Single Tests vs. Multiparameter Tests
- 3.4 DOA Screening
- 3.5 Porter's Five Forces Analysis
- 3.6 Future Outlook
- 3.7 Assessment of COVID-19's Impact on the Market
- Chapter 4 Market Dynamics
- 4.1 Market Drivers
- 4.1.1 Government Initiatives for Drug Abuse Testing
- 4.1.2 Increased Drug Trafficking
- 4.2 Market Restraints
- 4.2.1 Drug Testing at the Workplace Considered a Violation of Privacy Rights
- 4.3 Market Opportunities
- 4.3.1 Increasing Concern for Drink-Driving
- Chapter 5 Regulatory Scenario
- 5.1 North America
- 5.1.1 Canada
- 5.1.2 Mexico
- 5.1.3 The U.S.
- 5.1.4 State-level Marijuana Legalization
- 5.1.5 U.S. Department of Transportation
- 5.1.6 Drug Testing in the Military
- 5.1.7 Drug Testing for Welfare Recipients and Public Assistance
- 5.1.8 Drug Testing for Individuals Convicted of Drug Felonies
- 5.2 South America
- 5.2.1 Bolivia
- 5.2.2 Brazil
- 5.2.3 Colombia
- 5.2.4 Ecuador
- 5.2.5 Guyana
- 5.2.6 Paraguay
- 5.2.7 Peru
- 5.3 Central America and the Caribbean
- 5.3.1 Costa Rica
- 5.3.2 Cuba
- 5.3.3 El Salvador
- 5.3.4 Guatemala
- 5.3.5 Haiti
- 5.3.6 Jamaica
- 5.3.7 Nicaragua
- 5.3.8 Panama
- 5.3.9 Honduras
- 5.3.10 The Bahamas
- 5.3.11 The Netherlands Antilles
- 5.3.12 Trinidad and Tobago
- 5.4 Europe
- 5.4.1 Bosnia and Herzegovina
- 5.4.2 Denmark
- 5.4.3 France
- 5.4.4 Germany
- 5.4.5 Italy
- 5.4.6 Latvia
- 5.4.7 Norway
- 5.4.8 Romania
- 5.4.9 Sweden
- 5.4.10 Switzerland
- 5.4.11 The Netherlands
- 5.4.12 The U.K.
- 5.5 Asia-Pacific
- 5.5.1 Australia
- 5.5.2 Bangladesh
- 5.5.3 Bhutan
- 5.5.4 Cambodia
- 5.5.5 Hong Kong
- 5.5.6 India
- 5.5.7 Japan
- 5.5.8 Maldives
- 5.5.9 Myanmar
- 5.5.10 Nepal
- 5.5.11 New Zealand
- 5.5.12 Singapore
- 5.5.13 South Korea
- 5.5.14 Sri Lanka
- 5.5.15 Taiwan
- 5.5.16 Thailand
- 5.5.17 Vietnam
- Chapter 6 Global Drugs of Abuse Testing Market by Drug Type
- 6.1 Overview
- 6.2 Alcohol
- 6.3 Amphetamine and Methamphetamine
- 6.4 Cannabis/Marijuana
- 6.5 Cocaine
- 6.6 Opioids
- 6.7 Others
- Chapter 7 Global Drugs of Abuse Testing Market by End User
- 7.1 Overview
- 7.2 Drug Testing Laboratories
- 7.3 Hospitals
- 7.4 Workplaces
- 7.5 Others
- 7.5.1 U.S. Armed Forces Zero Tolerance Stance
- Chapter 8 Global Drugs of Abuse Testing Market by Sample Type
- 8.1 Overview
- 8.2 Blood Testing
- 8.2.1 Market Size and Forecast
- 8.3 Hair Testing
- 8.3.1 Market Size and Forecast
- 8.4 Oral Fluid Testing
- 8.4.1 Market Size and Forecast
- 8.5 Sweat Testing
- 8.5.1 Market Size and Forecast
- 8.6 Urine Testing
- 8.6.1 Market Size and Forecast
- 8.7 Other Testing
- 8.7.1 Market Size and Forecast
- Chapter 9 Global Drugs of Abuse Testing Market by Product
- 9.1 Overview
- 9.2 Analyzers
- 9.2.1 Market Size and Forecast
- 9.3 Consumables
- 9.3.1 Market Size and Forecast
- 9.4 Laboratory Services
- 9.4.1 Market Size and Forecast
- 9.5 Point-of-Care/Rapid Testing Devices
- 9.5.1 Market Size and Forecast
- Chapter 10 Global Drugs of Abuse Testing Market by Testing Type
- 10.1 Overview
- 10.2 Onsite Testing
- 10.2.1 Market Size and Forecast
- 10.3 Laboratory Testing
- 10.3.1 Market Size and Forecast
- Chapter 11 Market Breakdown by Region
- 11.1 Overview
- 11.2 North America
- 11.2.1 U.S.
- 11.2.2 Canada
- 11.3 Europe
- 11.3.1 Germany
- 11.3.2 U.K.
- 11.3.3 France
- 11.3.4 Rest of Europe
- 11.4 Asia-Pacific
- 11.4.1 China
- 11.4.2 Japan
- 11.4.3 India
- 11.4.4 Rest of Asia-Pacific
- 11.5 Rest of the World (RoW)
- 11.5.1 RoW Market Size and Forecast
- Chapter 12 Patent Analysis
- Chapter 13 Competitive Landscape Analysis
- 13.1 Overview
- 13.2 Company Ranking Analysis
- 13.3 Recent Developments and Initiatives
- Chapter 14 Company Profiles
- ABBOTT DIAGNOSTICS
- ACON LABORATORIES INC.
- AGILENT TECHNOLOGIES, INC.
- ALFA SCIENTIFIC DESIGNS, INC.
- AMERICAN BIO MEDICA
- BIO-RAD LABORATORIES, INC.
- CONFIRM BIOSCIENCES
- DANAHER CORP.
- F. HOFFMANN-LA ROCHE LTD.
- IDENTA CORP.
- LIFESIGN LLC
- MAVAND SOLUTIONS
- MEDTOX DIAGNOSTICS
- MOSSMAN ASSOCIATES
- MP BIOMEDICALS
- NANO-DITECH CORP.
- ONE STEP DETECT ASSOCIATES
- ORASURE
- ORTHO-CLINICAL DIAGNOSTICS
- PRECHEK BIO
- PRINCETON BIOMEDITECH
- PSYCHEMEDICS
- QUEST DIAGNOSTICS INC.
- RANDOX LABORATORIES LTD.
- REDWOOD TOXICOLOGY LABORATORY, INC.
- SHIMADZU CORP.
- SIEMENS HEALTHINEERS
- THERMO FISHER SCIENTIFIC, INC.
- UCP BIOSCIENCES
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook